- Chevron Contributes $5m to Fight HIV in Nigeria
Chevron Nigeria Limited, an affiliate of Chevron Corporation, has announced the disbursement of $2.5m donated by Chevron to the Global Fund to fight the acquired immune deficiency syndrome, tuberculosis and malaria for the implementation of the Chevron-Global Fund Anti-Retroviral Treatment Service Maintenance Programme in Delta, Bayelsa, Ondo and Lagos states.
It said a final instalment of $2.5m would be disbursed in 2018 to support these programmes, amounting to $5m by Chevron.
According to a statement, the funds are in addition to $6.7m earlier donated by Chevron to the prevention of mother-to-child transmission of the HIV in Bayelsa State.
The General Manager, Policy, Government and Public Affairs, CNL, Esimaje Brikinn, said, “The ART Programme will help bridge a critical national health gap and continue Chevron’s work in achieving an AIDS-free generation. The programme will help reduce new HIV infections and improve the quality of life for people living with HIV and other affected people in the communities of the targeted states.
“Additionally, it will provide Nigerians with universal access to high-quality, patient-cantered prevention, diagnosis and treatment services for tuberculosis, HIV and drug-resistant tuberculosis by 2020.”
According to the statement, the disbursements are part of a nine-year, $60m commitment from Chevron to the Global Fund. The Global Fund raises and invests nearly $4bn a year to support programmes run by local experts to fight the three diseases in countries and communities most in need.
The Global Fund is one of the world’s largest international financiers of healthcare programmes fighting the three diseases.
Brikinn said, “Chevron has learned through decades of experience that our success is tied to the health and prosperity of the communities where we operate.
“Chevron’s social investments are developed through a participatory process and through partnerships not only with the communities who are living in proximity to our operations, but also with other stakeholders who share interests in common with our business (such as government, non-governmental organisations, non-profits and development agencies).”